|Bid||262.10 x 800|
|Ask||282.33 x 800|
|Day's Range||278.26 - 283.18|
|52 Week Range||205.10 - 288.27|
|Beta (5Y Monthly)||0.78|
|PE Ratio (TTM)||73.16|
|Earnings Date||Oct 26, 2021|
|Forward Dividend & Yield||N/A (N/A)|
|Ex-Dividend Date||Nov 23, 2012|
|1y Target Est||298.80|
Subscribe to Yahoo Finance Plus to view Fair Value for MASILearn more
Masimo (MASI) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
IRVINE, Calif., October 18, 2021--An abstract presented at ANESTHESIOLOGY 2021 recommended use of noninvasive, continuous Masimo PVi® to guide fluid administration during oncosurgery.
Most investors tend to think that hedge funds and other asset managers are worthless, as they cannot beat even simple index fund portfolios. In fact, most people expect hedge funds to compete with and outperform the bull market that we have witnessed in recent years. However, hedge funds are generally partially hedged and aim at […]